Isabelle Klauck
Pierre Fabre (France)(FR)
Publications by Year
Research Areas
Hepatitis C virus research, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, Melanoma and MAPK Pathways, Cutaneous Melanoma Detection and Management
Most-Cited Works
- → ANCHOR CRC: Results From a Single-Arm, Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated BRAFV600E-Mutant Metastatic Colorectal Cancer(2023)91 cited
- → O-10 ANCHOR CRC: Results from a single-arm, phase 2 study of encorafenib, binimetinib plus cetuximab in previously untreated BRAF V600E–mutant metastatic colorectal cancer(2021)24 cited
- → Brief Report(2015)23 cited
- → Entecavir plus tenofovir combination therapy for chronic hepatitis B in patients with previous nucleos(t)ide treatment failure(2016)23 cited
- → Chronic Hepatitis B Monitoring and Treatment Patterns in Five European Countries with Different Access and Reimbursement Policies(2013)22 cited
- → COLUMBUS-AD: Phase III Study of Adjuvant Encorafenib + Binimetinib in Resected Stage IIB/IIC BRAF V600-Mutated Melanoma(2023)13 cited
- → Predictors associated with treatment initiation and switch in a real‐world chronic hepatitis B population from five European countries(2013)8 cited
- → Chronic Hepatitis B Treatment Initiation and Modification Patterns in Five European Countries: A 2-Year Longitudinal, Non-Interventional Study(2013)8 cited
- → Nephrolithiasis and renal failure among patients exposed to atazanavir, other PIs and PI‐free regimens(2014)5 cited
- → Safety and Efficacy of Atazanavir Powder and Ritonavir in HIV-1-Infected Infants and Children From 3 Months to <11 Years of Age(2017)4 cited